In a landmark case, Amazon has agreed to a $2.5 billion settlement over misleading Prime subscriptions. The FTC claims the company used deceptive practices to enroll users. Find out how this affects you!
Apple is facing a class action lawsuit over delayed Siri features, with plaintiffs claiming they misled consumers. Discover how this may impact you and what Apple says in response.
Microsoft has announced a no-cost option for Extended Security Updates (ESU) for Windows 10 users in the European Economic Area, responding to consumer rights concerns. This decision follows pressure from Euroconsumers, aiming to align with EU regulations and sustainability goals.
Amazon faces a staggering $2.5 billion penalty after the FTC found it misled customers into full Prime subscriptions. Affected users could claim up to $51 in refunds. Discover how you might benefit from this landmark ruling!
In a landmark decision, Amazon has agreed to pay $1.5 billion in refunds as part of a $2.5 billion settlement with the FTC, addressing claims of deceptive practices around its Prime subscription service.
A federal trial is underway in Seattle to determine if Amazon misled customers into Prime subscriptions and made cancellations difficult. The FTC alleges widespread legal violations by the retail giant.
A federal trial in Seattle will determine if Amazon deceived customers into signing up for Prime and made cancellation complicated. The FTC alleges violations of consumer protection laws.
Amazon is gearing up for a pivotal trial as the FTC accuses the retail giant of misleading customers about Prime membership sign-ups and cancellations. Jury selection begins Monday, with significant implications for consumer rights and Big Tech regulation.
The FTC has filed a lawsuit against Ticketmaster, accusing the company of misleading consumers about ticket prices and collaborating with scalpers to inflate resale rates, harming both fans and artists.
In a landmark decision, the Trump administration vows to overhaul the regulations on prescription drug advertising. This move aims to ensure consumers receive accurate information about the risks and benefits of medications, combatting misleading ads that favor expensive drugs over affordable generics.
